Bio-Rad Laboratories BIO Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories's operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories's operating lease liabilities (total)?
- Bio-Rad Laboratories (BIO) reported operating lease liabilities (total) of $174.8M in Q1 2026.
- How has Bio-Rad Laboratories's operating lease liabilities (total) changed year-over-year?
- Bio-Rad Laboratories's operating lease liabilities (total) increased by 4.3% year-over-year, from $167.6M to $174.8M.
- What is the long-term trend for Bio-Rad Laboratories's operating lease liabilities (total)?
- Over 5 years (2020 to 2025), Bio-Rad Laboratories's operating lease liabilities (total) has grown at a -3.0% compound annual growth rate (CAGR), from $211.6M to $181.8M.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.